| scholarly article | Q13442814 |
| P2093 | author name string | Jianping Li | |
| Ying Zhang | |||
| Mei Shi | |||
| Jing Hu | |||
| Xin Meng | |||
| Lichun Wei | |||
| Yunzhi Dang | |||
| P2860 | cites work | Unexpected new roles for heparanase in Type 1 diabetes and immune gene regulation | Q27009264 |
| Involvement of heparanase in atherosclerosis and other vessel wall pathologies | Q27025052 | ||
| Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation | Q27860876 | ||
| Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 | Q27861047 | ||
| Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis | Q28138868 | ||
| Hypoxia-inducible factor-1 alpha (HIF-1 alpha) escapes O(2)-driven proteasomal degradation irrespective of its subcellular localization: nucleus or cytoplasm | Q28343944 | ||
| Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response | Q30573416 | ||
| Heparanase Enhances Local and Systemic Osteolysis in Multiple Myeloma by Upregulating the Expression and Secretion of RANKL | Q34267974 | ||
| Role of heparanase in radiation-enhanced invasiveness of pancreatic carcinoma | Q34762351 | ||
| The development of inhibitors of heparanase, a key enzyme involved in tumour metastasis, angiogenesis and inflammation | Q35848243 | ||
| Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate towards tumour blood vessels | Q35916654 | ||
| Significance of heparanase in cancer and inflammation | Q36101233 | ||
| The potential of heparanase as a therapeutic target in cancer | Q36452903 | ||
| A critical review of patient-rated quality of life studies of long-term survivors of cervical cancer | Q36485050 | ||
| Heparanase: one molecule with multiple functions in cancer progression | Q37228578 | ||
| Targeting hypoxia, HIF-1, and tumor glucose metabolism to improve radiotherapy efficacy. | Q38052537 | ||
| Radical hysterectomy with pelvic lymph node dissection for treatment of cervical cancer: a clinical review of 954 cases | Q39474409 | ||
| Heparanase promotes bone destruction and invasiveness in prostate cancer | Q39981062 | ||
| Tumor suppressor p53 regulates heparanase gene expression | Q40317250 | ||
| Treatment regimen determines whether an HIF-1 inhibitor enhances or inhibits the effect of radiation therapy | Q41903043 | ||
| High expression of heparanase is significantly associated with dedifferentiation and lymph node metastasis in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA and via HIF1a to HB-EGF and bFGF. | Q43487753 | ||
| Radical hysterectomy for invasive cervical cancer. A 25-year prospective experience with the Miami technique | Q45008532 | ||
| Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study | Q45271357 | ||
| Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates. | Q50769115 | ||
| RTOG 0417: efficacy of bevacizumab in combination with definitive radiation therapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma. | Q53098455 | ||
| Heparanase as mediator of angiogenesis: mode of action | Q74101720 | ||
| A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study | Q82326945 | ||
| P433 | issue | 2 | |
| P921 | main subject | cervix uterine cancer | Q160105 |
| hypoxia | Q105688 | ||
| P304 | page(s) | 234-244 | |
| P577 | publication date | 2017-02-01 | |
| P1433 | published in | American Journal of Cancer Research | Q17511667 |
| P1476 | title | Heparanase promotes radiation resistance of cervical cancer by upregulating hypoxia inducible factor 1. | |
| P478 | volume | 7 |
| Q58585910 | Heparan Sulfate Mimetics in Cancer Therapy: The Challenge to Define Structural Determinants and the Relevance of Targets for Optimal Activity |
| Q59799492 | Inhibition of heparanase protects against chronic kidney dysfunction following ischemia/reperfusion injury |
| Q58616091 | Salidroside improves the hypoxic tumor microenvironment and reverses the drug resistance of platinum drugs via HIF-1α signaling pathway |
Search more.